NCT00039780 2022-07-13Evaluation of BNP7787 for the Prevention of Neurotoxicity in Metastatic Breast Cancer Patients Receiving Weekly PaclitaxelBioNumerik Pharmaceuticals, Inc.Phase 3 Completed764 enrolled
NCT00966914 2022-07-13Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus CisplatinBioNumerik Pharmaceuticals, Inc.Phase 3 Completed540 enrolled